ZAI LAB LIMITED Operating Lease, Expense
ZAI LAB LIMITED (ZLAB) reported Operating Lease, Expense of $2.71 million for the 9-month period ending 2019-09-30, per its 6-K filed 2020-01-21.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2020-04-29
- ZAI LAB LIMITED operating lease, expense for the quarter ending 2018-12-31 was $468.02K.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month | Operating Lease, Expense 12 month as first filed |
|---|---|---|---|---|
| 2019-09-30 | $2.71M 6-K · filed 2020-01-21 | |||
| 2018-12-31 | $468.02K derived: 20-F 12 month − 6-K 9 month · filed 2020-04-29 | $1.49M 20-F · filed 2020-04-29 | $1.49M 20-F · filed 2019-03-29 | |
| 2018-09-30 | $1.03M 6-K · filed 2020-01-21 | |||
| 2017-12-31 | $917.00K 20-F · filed 2020-04-29 | $916.61K 20-F · filed 2018-04-30 | ||
| 2016-12-31 | $285.74K 20-F · filed 2019-03-29 | |||
| 2015-12-31 | $148.27K 20-F · filed 2018-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |